LPS-INDUCED BRAIN INJURY IN PRETERM FETAL SHEEP IS MODULATED BY UMBILICAL CORD BLOOD THERAPY
Background: Up to 70% of all preterm births are complicated by chorioamnionitis. Chorioamnionitis during development can significantly increase brain injury and the risk of cerebral palsy, thus there is a need for new therapies. This study models preterm white matter injury and explores the therapeutic potential of stem cells isolated from human umbilical cord blood (UCB). It is hypothesised that stem cells will attenuate the brain injury associated with chorioamnionitis.
Method: White matter injury was induced in fetal sheep at 0.65 gestation. LPS (150 ng I.V., 055:B5), or saline for controls, was administered directly to the fetus over 3 consecutive days.
Stem cell-treated animals received 100 million UCB mononuclear cells (I.V.), 6 hours after the final LPS dose. Brains were collected for analysis at 10 days after the final LPS dose.
Results: LPS administration increased microglial activation (Iba-1) and cell death (Cas-3, p < 0.05) in the subcortical white matter and cortex, compared to controls. UCB attenuated this injury. LPS administration also resulted in increased spleen and adrenal weights, indicating a systemic immune/stress response.
Conclusions: UCB treatment reduced white matter injury following LPS-induced brain injury. Future studies will examine if cord tissue stem cells or repeated doses provide even greater benefit. Aim: To compare neonates receiving nCPAP in tertiary and non-tertiary centres, to determine any differences in caseload, management and outcome.
COMPARISON OF NEONATES RECEIVING NASAL CPAP IN TERTIARY AND NON-TERTIARY CENTRES
Method: Retrospective data analysis over five years 2010-2014 (6 sites). Preliminary data set (2 sites) of non-tertiary subjects ?32 weeks, ?1500 g receiving nCPAP (via bubble CPAP or ventilator) for respiratory distress within their first 24 hours (n = 73) were compared with a similar cohort of (randomly selected) inborn neonates at a tertiary centre (n = 341). Analysis conducted using SPSSv22. Main outcome measures: maternal/ neonatal demographics; CPAP duration; pneumothorax and nasal trauma rates; enteral feeds during nCPAP; and caffeine.
Results: Non-tertiary subjects were more likely to be singleton males; born via elective caesarean section (p =.001); and receive a chest x-ray (p <.001). Tertiary subjects were more likely to receive feeds (p =.03) and caffeine (p =.01). Duration of nCPAP differed between centres (p <.001) with tertiary centres using nCPAP more often for short periods of time (<6 hours). There was no difference with nasal trauma or pneumothorax rates. There was no difference in nursery length of stay for neonates discharged home (p =.38).
Conclusions: Preliminary data suggests that there are minor differences in caseload, some variation in management and little difference evident in outcomes.
